Institute launches a new AI initiative to power biological research
With artificial intelligence (AI) poised to greatly accelerate the pace for novel discoveries in foundational biological research, the Stowers Institute launched the Office of Scientific Leadership AI Initiative, a new program designed to advance capabilities in machine learning and AI for addressing critical biological questions. Investigator Julia Zeitlinger, Ph.D., has been appointed to lead this effort and leverage cutting-edge computational techniques to accelerate scientific discoveries and drive innovation in biological research.
Zeitlinger will work to develop and execute a long-term strategy to build world-class AI-powered computational expertise. She will head the steering committee that, together with Chief Information Officer Evelyn Travnik and Director of Scientific Data Jay Unruh, Ph.D., prioritizes and implements computational efforts across the organization. She also advises the Stowers Fellows program and the Graduate School to attract, support, and maintain computational talent at the Institute.
“Biology is incredibly complex, and AI is an excellent way to detect the underlying patterns and rules. A great example is the information encoded in our DNA, how it us used to create gene products like proteins, and how those gene products function to support life,” said Zeitlinger. “I am passionate about leading the Institute’s new initiative to promote AI in our scientific research. It is both an exciting challenge and a huge opportunity.”
A fundamental biological quest is to understand how variations within our genetic code and the molecules arising from it not only make us unique but can also underlie disease or disease susceptibility. AI’s predictive capabilities can guide targeted experimental approaches to identify how these variations impact gene regulation and protein function, key factors governing development, health, and disease.
“Many of our investigators including Zeitlinger and our Technology Center scientists are engaged in the pursuit of understanding how sequences within our DNA genetic blueprint control gene activity and how the shape of proteins affects their function,” said Stowers Scientific Director Kausik Si, Ph.D.
“Leveraging the power of AI will enable researchers Institute-wide to answer questions that remain some of the biggest biological mysteries for the benefit of all,” said Stowers President and Chief Scientific Officer Alejandro Sánchez Alvarado, Ph.D.
This article is republished from Stowers News. Read the original here.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
When things get SAPpy: Novel insights into complement
Researchers have defined interactions between an innate immune protein and two of its known binding partners. They identified potential areas of crosstalk between the two binding interactions.
Glutathione pathway implicated in rare disease
Researchers found that glutathione metabolism plays a central role in the pathogenesis of rare disease methylmalonic aciduria using a novel multiomics approach.
A p-value for proteins
Kyoto University researchers developed UniScore, a new tool that uses a target-decoy method to filter false positives in proteomic searches, helping scientists set thresholds and improve reliability when analyzing complex protein data.
Novel way to uncover tumor microenvironment proteomics
Researchers at the Weizmann Institute of Science developed a novel single-cell approach that facilitates the study of proteins surrounding lung cancer cells.
Sizing up cells: How stem cells know when to divide
Stanford University researchers find that stem cells control their size early in cell division across living multicellular systems.
When oncogenes collide in brain development
Researchers at University Medical Center Hamburg, found that elevated oncoprotein levels within the Wnt pathway can disrupt the brain cell extracellular matrix, suggesting a new role for LIN28A in brain development.